These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12470807)

  • 21. Persistence of Aβ seeds in APP null mouse brain.
    Ye L; Fritschi SK; Schelle J; Obermüller U; Degenhardt K; Kaeser SA; Eisele YS; Walker LC; Baumann F; Staufenbiel M; Jucker M
    Nat Neurosci; 2015 Nov; 18(11):1559-61. PubMed ID: 26352792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
    Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
    Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
    Johnson-Wood K; Lee M; Motter R; Hu K; Gordon G; Barbour R; Khan K; Gordon M; Tan H; Games D; Lieberburg I; Schenk D; Seubert P; McConlogue L
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1550-5. PubMed ID: 9037091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid Beta Peptide.
    Pawlik M; Sastre M; Calero M; Mathews PM; Schmidt SD; Nixon RA; Levy E
    J Mol Neurosci; 2004; 22(1-2):13-8. PubMed ID: 14742906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease.
    Leskovjan AC; Lanzirotti A; Miller LM
    Neuroimage; 2009 Oct; 47(4):1215-20. PubMed ID: 19481608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
    Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
    J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins.
    Janssen L; Keppens C; De Deyn PP; Van Dam D
    Biochim Biophys Acta; 2016 Jan; 1862(1):105-12. PubMed ID: 26542217
    [No Abstract]   [Full Text] [Related]  

  • 29. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.
    Park JH; Gimbel DA; GrandPre T; Lee JK; Kim JE; Li W; Lee DH; Strittmatter SM
    J Neurosci; 2006 Feb; 26(5):1386-95. PubMed ID: 16452662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New plaque-boosting protein a possible Alzheimer target.
    Voelker R
    JAMA; 2010 Oct; 304(13):1431. PubMed ID: 20924003
    [No Abstract]   [Full Text] [Related]  

  • 32. Trans-Synaptic Spread of Amyloid-
    Pignataro A; Middei S
    Neural Plast; 2017; 2017():5281829. PubMed ID: 29435372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
    Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
    Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease: amyloid beta-peptide antibody vaccine as plaque remover.
    Kumar A
    J Biosci; 2000 Dec; 25(4):315-6. PubMed ID: 11120582
    [No Abstract]   [Full Text] [Related]  

  • 35. Copper and Alzheimer's Disease.
    Mathys ZK; White AR
    Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia].
    Shoji M; Hirai S
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890
    [No Abstract]   [Full Text] [Related]  

  • 37. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
    Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D
    Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
    Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer disease: Alzheimer dementia with sparse amyloid-AD mimic or variant?
    Serrano-Pozo A; Hyman BT
    Nat Rev Neurol; 2015 Dec; 11(12):674-5. PubMed ID: 26553593
    [No Abstract]   [Full Text] [Related]  

  • 40. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
    Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
    Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.